MedPath

CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation

Not Applicable
Completed
Conditions
Presbyopia Correction
Interventions
Device: Test (multi-focal)
Device: Control (Sphere)
Registration Number
NCT02147093
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

A comparative evaluation of a newly marketed multifocal contact lens with a single vision contact lens when used with near vision spectacles. The evaluation was to quantify the difference between the two test corrections.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  1. Age 45 years or more
  2. Spectacle or soft contact lens wearer
  3. Refraction: best sphere (corrected for back vertex distance) -6.00 Diopters (D) to +4.00 D; Astigmatism - 0.00 D to -0.75 D; Near addition for 40 cm; Medium Add: +1.50 D to +2.00 D; High Add: +2.25 D to +2.50 D
  4. Best spectacle corrected visual acuity of 6/9 or better in each eye
  5. Willingness to adhere to the instructions set forth in the clinical protocol
  6. Signature of the subject Informed Consent form after review of Information to Participant document.
Exclusion Criteria
  1. Systemic or ocular allergies which might interfere with contact lens wear
  2. Systemic disease which might interfere with contact lens wear
  3. Ocular disease which might interfere with contact lens wear (e.g. hypothesia, insufficient lacrimal secretion)
  4. Use of medication which might interfere with contact lens wear
  5. Active ocular infection
  6. Use of ocular medication
  7. Significant ocular anomaly
  8. Presence of two or more corneal scars in either eye
  9. Monovision contact lens wearers
  10. Pregnancy or lactation
  11. Any medical condition that might be prejudicial to the study
  12. Participants non-able to give consent or from a vulnerable group
  13. Infectious disease (for example, hepatitis, tuberculosis, etc.) or a contagious immunosuppressive disease (such as HIV, AIDS, etc.)
  14. Employees or family member of the investigational clinic (e.g. investigator, coordinator, technician)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Test (sphere) /Control (multi-focal)Test (multi-focal)Subjects were first fitted with the Test lens (multi-focal) for one week. Subjects were then fitted with Control lens (sphere) and a pair of reading glasses for one week.
Control (sphere) /Test (multi-focal)Control (Sphere)Subjects were first fitted with Control lens (sphere) and a pair of reading glasses for one week. Subjects were then fitted with the Test lens (multi-focal) for one week.
Test (sphere) /Control (multi-focal)Control (Sphere)Subjects were first fitted with the Test lens (multi-focal) for one week. Subjects were then fitted with Control lens (sphere) and a pair of reading glasses for one week.
Control (sphere) /Test (multi-focal)Test (multi-focal)Subjects were first fitted with Control lens (sphere) and a pair of reading glasses for one week. Subjects were then fitted with the Test lens (multi-focal) for one week.
Primary Outcome Measures
NameTimeMethod
Distance LogMAR Visual Acuity7 days post wear

Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m\^2 and 2.5 cd/m\^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m\^2) High Contrast (90%) \& Low Contrast (10%) and Low Luminance (2.5 cd/m\^2) High Contrast (90%)

Near LogMAR Visual Acuity7 days post wear

Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m\^2 and 50 cd/m\^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m\^2) High Contrast (90%) \& Low Contrast (10%) and Low Luminance (50cd/m\^2) High Contrast (90%)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath